Jeevtronics Pvt. Ltd.
World’s first triple-powered cost-effective defibrillator
CURRENT IMPACT
As on August 2023
280+
Defibrillators deployed
30%
Devices deployed in tier 2 and 3 towns
Geographical Focus
- PAN India
Potential Impact
- Reach
1.5 million
lives
Ashish Gawade Co-founder, Jeevtronics Pvt Ltd
SAMRIDH has fully understood Jeevtronic’s growth journey and has extended support not just financially, but also with technical assistance to help address the inherent challenges within our ecosystem. Through this partnership, we have been able to expand our reach into underserved markets, cultivate our marketing strategy, and enhance our products through advanced research and development efforts.
Samridh support
SAMRIDH’s initial partnership with Jeevtronics entailed providing financial assistance to enhance the sales and distribution activities of SanMitra 1000 HCT Biphasic Defibrillator. This support has been further complemented with business advisory services to help Jeevtronics in designing a commercial strategy to increase its market presence and build a steady pipeline of orders. The support from SAMRIDH has further enabled Jeevtronics to secure affordable working capital loans from financial institutions. This allows the company to service the new order flow, achieve long-term sustainability, and expand to hospitals with low resources.
6,00,000
Sudden cardiac arrest causes deaths per year in India[1]
16.7
%
COVID-19 patients suffer from arrhythmias, a condition causing irregular or abnormal heartbeats[2]
1
in
50
Only ICU beds have a defibrillator[3]
Sudden Cardiac Arrest (SCA) is a condition where the heart suddenly stops, leading to a person’s death. COVID-19 patients who suffer an SCA, either in or out of hospitals, are far more likely to lose their lives than those not infected with the coronavirus. Cardiac arrests and arrhythmias can be managed with a medical device called ‘Defibrillator’ which helps in restoring the normal heart rhythm by applying a high voltage shock across the heart. However, most hospitals in India do not have access to a defibrillator. In addition, since accident trauma patients are more likely to go into cardiac arrest, the presence of defibrillators in trauma ambulances is critical. Yet, only about 25% of the ambulances have defibrillators.
[1] Rao B. H. (2014). Global burden of Sudden Cardiac Death and insights from India. Indian heart journal, 66 Suppl 1(Suppl 1), S18–S23.
[2] Wang D, Hu B, Hu C, et al.Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. Published online February 07, 2020
[3] Grassroots Innovation Database by United Nations Development Programme (UNDP) India and Honeybee Network
SanMitra 1000 HCT Biphasic Defibrillator
Jeevtronics offers a low maintenance, cost-effective, lifesaving, hand-cranked defibrillator – SanMitra 1000 HCT Biphasic Defibrillator, India’s first dual powered hand cranked defibrillator. This produce is triple powered as well as ambulance grade approved. It can be charged from the AC mains within 6-7 seconds and is priced at less than 25% of the cost of conventional defibrillators. Its longevity, affordability, and ability to operate without electricity enables healthcare workers to provide quality care and avoid preventable deaths. Jeevtronics is also working on product upgrades for ambulances and IoT-enabled models to maximise the benefits, resulting in overall cost savings for the end-user.
Key Stakeholders
